| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |
| 05/07/1997 | CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/07/1997 | CN1149051A Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha1 adrenergic receptor antagonists |
| 05/07/1997 | CN1148982A Sikang Shennong Yangsheng Health-care pellet |
| 05/07/1997 | CN1148961A Pellet for generation of semen |
| 05/07/1997 | CA2189401A1 Purin-6-one derivatives |
| 05/06/1997 | US5627198 Blood metal concentrations |
| 05/06/1997 | US5627197 Piperidino- or piperazino-substituted oxazolidinone, thiazolidinones or imidazolidinones |
| 05/06/1997 | US5627182 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 05/06/1997 | US5627154 Calcium channel blocking polypeptides from Heteropoda venatoria |
| 05/06/1997 | US5626846 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 05/02/1997 | EP0770612A1 Terazosin crystalline polymorph and pharmaceutical compositions thereof |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
| 05/02/1997 | EP0770388A1 Multiphase contraceptive preparation based on natural estrogens |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0769956A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 05/02/1997 | EP0769941A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 05/01/1997 | WO1996028154A3 Use of anti-oestrogens as male contraceptives |
| 05/01/1997 | CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates |
| 05/01/1997 | CA2233882A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 04/30/1997 | CN1148807A Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 04/30/1997 | CN1148590A Sulfuryl or sulfinyl benzoyl guanidine derivative |
| 04/29/1997 | US5624944 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 04/29/1997 | US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 04/29/1997 | US5624670 Use of interleukin-8 for inducing cervical ripening |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997011680A3 Hormone replacement therapy method and hormone dispenser |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0768878A1 Endothelin receptor antagonists |
| 04/23/1997 | EP0600873B1 Therapeutically effective topical application of st1435 |
| 04/23/1997 | EP0563249B1 Targeting of therapeutic agents using polysaccharides |
| 04/23/1997 | CN1148340A Method for treating 5HT2B receptor related conditions |
| 04/23/1997 | CN1148335A Mucoadhesive emulsion contg. cyclodextrin |
| 04/22/1997 | US5622962 Prostate cancer, skin disorders, baldness |
| 04/22/1997 | US5622961 5α-reductase inhibitors |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/17/1997 | WO1997013758A1 Pyridazinones as endothelin-receptor antagonists |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | CA2207243A1 Endothelin receptor antagonists |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767798A1 Sterol derivatives used for regulation of meiosis |
| 04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
| 04/16/1997 | EP0767787A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 04/16/1997 | EP0767773A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0767660A1 Methods and formulations for modulating the human sexual response |
| 04/16/1997 | EP0767659A1 Transdermal administration of oxybutynin |
| 04/16/1997 | EP0609345A4 Biocompatible implant for the timing of ovulation in mares. |
| 04/16/1997 | EP0536282B1 Meducament for treating prostatic adenocarcinoma |
| 04/16/1997 | CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/16/1997 | CN1147406A Cockscomb beverage |
| 04/16/1997 | CN1147400A Fukang granule for women and its prepn |
| 04/16/1997 | CN1147399A Prepn process of multi-purpose sanitary embolus |
| 04/16/1997 | CN1147384A Compound silk moth essence |
| 04/16/1997 | CN1147375A Multifunctional collyrium for women |
| 04/16/1997 | CN1034569C Endothelin receptor antagonists |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620701 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012631A1 Drug for ameliorating renal function |
| 04/10/1997 | WO1997012624A1 Novel peptides |
| 04/10/1997 | WO1997012618A1 Gel for the local hormonotherapy of vaginal dryness |
| 04/10/1997 | DE19537548A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 04/10/1997 | CA2233923A1 Gel for the local hormonotherapy of vaginal dryness |
| 04/10/1997 | CA2233272A1 Novel peptides |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | EP0693878B1 Iodine barrier teat dip |
| 04/09/1997 | CN1147251A Tetrasubstd. imidazole derivs., method for preparing same, resulting intermediates, use thereof as drug, and pharmaceutical composition contg. same |
| 04/08/1997 | US5618941 Benzenealkanoic acids for cardiovascular diseases |
| 04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 04/08/1997 | US5618537 Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organ |
| 04/03/1997 | WO1997011680A2 Hormone replacement therapy method and hormone dispenser |
| 04/03/1997 | CA2232621A1 Hormone replacement therapy method and hormone dispenser |
| 04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
| 04/02/1997 | EP0765661A2 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0655089A4 Effects of actin filaments on fibrin clot structure and lysis. |
| 04/02/1997 | CN1146765A Use of imidazole derivatives for treating disorders involving angiotensin receptors AT 1 and AT2, certain such products preparation thereof, use thereof as drugs, and pharmaceutical composition contai |
| 04/02/1997 | CN1034391C Preparation for intravaginal devices |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010821A1 Enhancement of erectile function with renin-angiotensin system inhibitors |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | CA2232360A1 Enhancement of erectile function with renin-angiotensin system inhibitors |